AI-generated summary
The authors studied whether a noninvasive photobiomodulation therapy could reduce free fatty acid release from fat tissue in high-fat diet-fed mice and diabetic db/db mice. They report that the therapy lowered fatty acid and triglyceride levels in both models and improved insulin resistance through a mitochondrial reactive oxygen species and AKT pathway, based on mouse and cell experiments.
- Who or what was studied
- High-fat diet-fed mice, diabetic db/db mice, and insulin-resistant adipocytes
- Limits stated in the abstract
- The findings come from mouse models and in vitro cell experiments, and the abstract does not report human participants.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Reactive oxygen species, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.